The tumor suppressor p53 is a master sensor of stress, and posttranslational modifications are key in controlling its stability and transcriptional activities. p53 can be phosphorylated on at least 23 Ser/Thr residues, the majority of which are phosphorylated by stress-related kinases. An exception is Ser315 in human p53 (Ser312 in mouse), which is predominantly phosphorylated by cell cyclerelated kinases. To understand the biological importance of Ser312 phosphorylation in vivo, we generated p53Ser312Ala knock-in mice. We show here that, although Ser312 is not essential for mouse life span under normal physiological conditions, Ser312Ala mutation dampens p53's activity during embryonic development. This is evident from its partial rescue of embryonic lethality caused by Mdm4 deletion. In agreement with the notion that Ser312 mutation weakens p53 function, Ser312Ala mice are also more susceptible to tumorigenesis following a sublethal ionizing radiation dose. Importantly, in the cohort studied, Ser312 mutation predisposes mice to develop thymic lymphomas and liver tumors, partly due to p53Ser312Ala's inability to fully induce a set of p53 target genes including p21 and cyclin G1. Thus, we demonstrate that phosphorylation of Ser312 is required for p53 to function fully as a tumor suppressor in vivo.
O ne of the best studied tumor suppressor genes is p53. The importance of its tumor suppressive role is illustrated in humans by the congenital Li-Fraumeni syndrome, where a mutation in the p53 gene results in the development of a range of malignancies, and the observation that the p53 gene undergoes inactivating mutations in around 50% of human tumors. p53 is normally present in the cell at low levels but increases in abundance in response to cellular stresses such as DNA damage, largely due to inhibition of its proteasomal degradation. Once elevated, it prevents potentially harmful damage being incurred following cell division, either by stalling the cell cycle until the damage is repaired or by preventing division entirely by inducing apoptosis or senescence. This is achieved largely by its ability to act as a transcription factor and by its regulation of target genes involved in various biological functions.
p53 is subject to many posttranslational modifications, such as acetylation and phosphorylation, which seem to both stabilize p53 and activate its transcriptional activity (1, 2) . p53 is phosphorylated at 23 sites, mostly found within the N-and C-terminal domains that form the molecule's regulatory regions. Most of these serine and threonine residues are phosphorylated by stressrelated kinases such as ATM/ATR and Chk2. However, Ser315 of human p53 (Ser312 in mouse) is phosphorylated by kinases involved in cell cycle progression, such as Aurora kinase A and the cyclin-dependent kinases cdk2 and cdk9 (3) (4) (5) (6) . Ser315 phosphorylation is required for the E2F family to enhance p53-mediated transcription and apoptosis (7) and is one of the sites phosphorylated when it interacts with the peptidyl-prolyl isomerase Pin1 following DNA damage to alter its conformation and increase its stability and transactivation activity (8, 9) . Although phosphorylation at Ser315 in these instances seems to elevate p53 stability and positively contribute to tumor suppression, its phosphorylation by Aurora kinase A (involved in chromosome segregation and function) results in its destabilization (5) . Following endoplasmic reticulum stress, phosphorylation of Ser315 alongside Ser376 results in p53's relocation to the cytoplasm, inhibiting p53-mediated apoptosis (10) . This suggests that Ser315 phosphorylation may obstruct p53's role in tumor suppression.
To establish a physiological role for the phosphorylation of p53 at Ser315, we generated mice possessing a Ser → Ala mutation at codon 312 (equivalent to human codon 315). p53Ser312Ala mice were born normally and displayed no overt phenotype. However, following a sublethal dose of ionizing radiation (IR), they were more susceptible to tumor development, particularly in the thymus and liver. We conclude that Ser312 phosphorylation contributes to tumor suppression by p53 in response to ionizing radiation in vivo.
Results
Phosphorylation of p53 at Ser312 Does Not Affect Mouse Life Span.
Ser312 in murine p53 is equivalent to Ser315 in human p53 (Fig.  1A) . To study the physiological effects of phosphorylating p53 at Ser312, knock-in mice were generated carrying a TCT → GCC (Ser → Ala) mutation in codon 312 of the mouse p53 gene (Fig.  S1 ). The mutation was identified by PCR using primers specific for either the wild-type (WT) or mutant allele. p53 cDNA was isolated by RT-PCR from p53 WT , heterozygous (p53 312A/+ ) and mutant (p53 312A/A ) littermates, and the mutation was confirmed by sequencing (Fig. 1B) . The entire p53 ORF was sequenced to confirm that no other mutations were present.
Mice homozygous for Ala at codon 312 (p53 312A/A mice) were viable, displayed no obvious developmental abnormalities, were born at the expected frequency (Fig. 1C) , and survived to maturity. Cohorts of 11 p53   WT   , 25 p53   312A/+   , and 18 p53 312A/A mice with a similar gender distribution for each genotype were followed over a period of 2 y to determine whether the mutation had a detrimental effect on life span. The p53 312A/A mice survived for a time period comparable to the p53 WT and p53 312A/+ mice and did not develop spontaneous tumors at a significantly higher rate (P > 0.05) (Fig. 1D) .
To verify that phosphorylation was not occurring in the p53 312A/A mice, an antibody was raised against the phosphorylated Ser312 residue in WT p53. Using this antibody, Ser312 was phosphorylated in p53 WT mouse embryonic fibroblasts (MEFs) but not in p53
MEFs following immunoprecipitation with an antibody to total p53 (Fig. 1E , top left). As Ser312 has been reported to be phosphorylated in response to UV (11), UV-irradiated MEFs were analyzed with the anti-phosphoserine 312 antibody. Although Ser312 phosphorylation is undetecteable in nonirradiated MEFs, Ser312 is phosphorylated 8h after UV irradiation in WT, but not p53
312A/A cells, confirming the antibody's specificity (Fig. 1E , Top Right). Next, we determined whether Ser312 is phosphorylated following IR. Phosphorylation of p53 at Ser312 could not be detected using this antibody after IR (Fig. 1E , Middle). As MEFs are primary cells, we transformed them with adenovirus E1A and analyzed Ser312 phosphorylation after IR in cells undergoing oncogenic stress. Ser312 was able to be phosphorylated in p53 WT E1A-transformed cells, although not in p53 312A/A cells (Fig. 1E , Bottom). We measured the ability of p53 WT versus p53 312A/A to influence the ability of E1A to immortalize MEFs. The difference was very small and not statistically significant, which agrees with the subtle effect of the mutation (Fig. S2) . To investigate whether Ser312 could affect the activity of p53, we used a system in which p53 activity was elevated. In mice, the targeted deletion of Mdm4, an inhibitor of p53, results in increased p53 activity and embryonic lethality. This embryonic lethality can be entirely overcome by the simultaneous deletion of p53 (12) (13) (14) (Fig. 2B) . However, the number of Mdm4
312A/A embryos obtained at E10.5 was 100% of the predicted number based on Mendelian segregation, suggesting that Ser312Ala mutation may reduce p53's activity.
This hypothesis was supported by the frequency of embryos recovered at later stages of development (up to E13.5). Sixty-nine embryos were examined at E12. 5 Fig. 2B . A similar trend was also seen in embryos collected at E13.5 ( Fig. 2A and Table 1 ). In a cohort of 106, we unexpectedly obtained 2 Mdm4
WT embryos. Embryos isolated at E13.5 were used to make MEFs. Of the two Mdm4
WT embryos isolated at this stage, only one produced cells that grew, albeit slowly (Fig. 2C) . Similarly, although six 
Mdm4
−/− p53 312A/+ embryos were identified, only one produced viable cells. However, fibroblasts from 3/5 Mdm4
embryos were able to proliferate in culture (Fig. 2C ). Very few Mdm4-null embryos were obtained at E14.5 irrespective of p53 status (Table 1) . Therefore, p53Ser312Ala mutation in one or both alleles can partially protect against embryonic lethality caused by Mdm4 loss, suggesting that Ser312 phosphorylation is necessary for p53 to be fully active.
Tumor Predisposition in p53
312A/A Mice Exposed to Ionizing
Irradiation. To discover whether p53 312A/A mice are more susceptible to tumor formation following exposure to a carcinogenic inducer, we exposed 3-wk-old mice to a single 4-Gy dose of IR. The study group consisted of 16 p53 WT (8 females and 8 males), 21 p53 312A/+ (10 females and 11 males), and 22 p53 312A/A (12 females and 10 males) mice. This cohort had a mixed 129SvEv/C57BL6/J/ FVB background and so had black, agouti, or white coats (10 agouti, 21 black, and 28 white) (Table S1) 3A) . The types of tumors observed included lymphomas, sarcomas, and solid tumors in liver and lung (Fig. 3B) . The experiment was terminated at 90 wk post irradiation, and the remaining mice were tumor-free at the end of the study.
The increased tumor susceptibility of p53 312A/A mice in response to IR implies that phosphorylation of murine p53 at Ser312 contributes to p53's tumor suppression in response to IR. We observed biphasic tumor onsets (25-52 wk and 70-90 wk) in this study, with an intervening 18-wk tumor-free period. Importantly, p53
312A/A mice were significantly more prone to tumor development than p53
WT or p53 312A/+ mice in both phases.
Mice Carrying the Ser312Ala Mutation Are Initially Susceptible to Lymphoma Development. The tumors that developed within the first phase of tumor onset (25-52 wk) were almost all lymphomas, the exception being a sarcoma found in the intestinal wall of a p53 312A/A mouse. The lymphomas found between 26 and 40 wk of age were all thymic lymphomas (n = 5; 22.7% of all p53 312A/A mice). In contrast, lymphomas that arose between 42 and 52 wk (n = 3; 13.6%) were generalized lymphomas that had disseminated to the liver and kidney (Fig. 4B) . The affected tissues from the three mice with generalized lymphomas were stained for Band T-cell markers to determine their origin. One stained positively for the T-cell marker CD3 (Fig. 4B) , whereas the other mice did not show positive staining for either CD3 or the B-cell marker B220. Disregarding the sarcoma, p53
312A/A mice were significantly more susceptible to lymphoma development (p53 312A/A vs. p53 312A/+ , P = 0.0093; p53 312A/A vs. p53
WT , P = 0.0345) (Fig. 4A ). All of the p53 312A/A mice that developed lymphomas (n = 8) had a white coat. Five of the eight mice were female, indicating that there was no gender bias in lymphoma development in this cohort. The majority of p53 312A/+ and p53 WT mice with white coats were tumor-free at this stage of the study. These data demonstrate that p53 312A/A mice are predisposed to lymphomas and that their genetic background may influence tumor development.
As a link has been made between the development of thymic lymphomas in p53-null mice and the resistance of their thymocytes to DNA damage-induced apoptosis (15-18), we investigated whether the Ser312Ala mutation could compromise p53's induction of apoptosis in response to IR. Thymocytes from p53 WT and p53
312A/A mice were exposed to a variety of apoptotic stimuli, including IR, and apoptosis was assessed by Annexin V binding (Fig. S3) . Little difference was detected in the levels of apoptosis induced by any of the stimuli. Therefore, apoptotic failure is not behind the increased incidence of thymic lymphomas seen in p53 312A/A mice. (Fig. 5A) . In contrast, only 1 p53 (Fig. 5A ). The p53
312A/A mice that developed liver tumors were mainly black (4/5 mice), and 4/5 of the liver tumors occurred in females, suggesting that there might be a gender and strain bias in this cohort for the development of liver tumors. Histological analysis revealed that, although the hyperplasias in these mice were frequently benign, one liver displayed hepatocellular carcinoma (Fig. 5B , Lower Left and Lower Right) that had metastasized to the large intestine. The surrounding liver tissue in the afflicted mice was also frequently found to show circular, unstained areas consistent with the presence of lipid droplets. In addition, one p53 312A/A mouse (female, black coat), killed at this point as it had developed a prolapse, was found to have a highly abnormal, fatty liver although it had not developed any hyperplasia. Therefore, a p53 Ser312Ala mutation can confer sensitivity to liver hyperplasia following IR. To better understand the mechanism by which Ser312 phosphorylation contributes to p53's tumor suppression, we undertook a genome-wide gene array analysis using the Affymetrix GeneChip Whole Transcript Sense Target Labeling Assay. Due to the increased incidence of liver tumors in p53 312A/A mice, the analysis was carried out using mRNA from the livers of two pairs of p53 WT and p53 312A/A littermates that were either untreated or isolated 6 h after receiving a 4-Gy dose of IR. A p53 response has been previously detected in the liver at this time point (19) and is consistent with the phosphorylation of p53 at Ser312 seen in E1A-transformed MEFs (Fig. 1E) . As expected, the expression levels of many genes, including some well-known p53 targets, were altered following IR (Table 2) , although known p53-responsive genes such as Mdm2, Noxa, and Puma showed an insignificant change in expression after irradiation in both p53
WT and p53 312A/A mice. However, the spectrum of genes affected differed considerably between the two samples (Fig. 6A ). There were 124 genes whose expression was changed in p53
WT but not in p53 312A/A mice; however, these genes were not recognized p53 target genes.
The recognized p53-responsive genes whose expression differed to the greatest degree were p21 and cyclin G1 ( Table 2 ). To validate our array data, quantitative RT-PCR was performed to measure the expression levels of p21 mRNA in p53 WT versus p53 312A/A mouse livers, with or without IR. Without IR, the levels of p21 and cyclin G1 mRNA in WT and mutant livers were comparable. However, after IR exposure, the increase in p21 and cyclin G1 mRNA was significantly less in p53 312A/A mice than in WT mice ( Fig. 6B and Table S2 ). In agreement, there was a small reduction in the level of p21 protein induced in p53 312A/A livers in response to IR (Fig. 6C) . This is further supported by the data obtained in p53 wt versus p53 312A/A MEFs (Fig. 6D) , where p21 expression was lower with mutant p53, especially in the absence of Mdm4. These data suggest that phosphorylation at Ser312 enhances p53's transcriptional activity.
By fine-tuning the actions of p53, Ser312 phosphorylation may have only a subtle effect on the expression of its target genes. However, when these effects are combined, they may be sufficient to mount a cellular response that is biologically significant following a genotoxic challenge such as IR. Our data demonstrate that despite possessing a mutation at only a single phosphorylation site, the Ser312Ala mutation confers increased susceptibility to tumorigenesis following IR exposure, especially in the thymus and, unusually, in the liver.
Discussion
In this study, we used knock-in mice carrying a Ser312Ala mutation in the p53 gene to investigate how phosphorylation at this site contributes to p53 function. As may be expected from a single amino acid change not known to be carcinogenic, these mice are viable and do not develop spontaneous tumors. This suggests that Ser312 does not influence p53's role in development and life span under normal conditions and agrees with findings in similar mice: Ser18Ala (human Ser15), Ser23Ala (human Ser20), and Ser389-Ala (human Ser392) knock-in mice all have minimal phenotypic abnormalities under normal conditions (20) (21) (22) . The finding is also consistent with the hypothesis that phosphorylation of p53 may have a role in fine-tuning its regulation, evident only when p53 activity increases above a certain threshold. However, following exposure to IR, p53 Ser312 mutant mice have a greater predisposition to tumors, particularly in the thymus and liver. The occurrence of thymic and T-cell lymphomas is common in mice with mutations in their p53 pathways, especially following irradiation (15, 18, 23) . The time of onset for lymphomas in p53
312A/A mice (26-52 wk) is comparable to that seen in p53 +/− mice exposed to 4 Gy irradiation (20-50 wk) (15) . However, unlike p53 +/− mice, p53 312A/A mice do not develop spontaneous lymphomas as tumors were seen only following irradiation.
Although we do not yet know the precise mechanism whereby Ser312Ala mutation causes thymic lymphomas, the fact that p53 312A/A mice with a defined genetic background develop lymphomas relatively rapidly following IR demonstrates that Ser312 plays an important suppressive role in lymphoma development. This distinguishes p53 312A/A mice from those with mutations at Ser18, Ser23, or Ser389, which do not develop lymphomas either spontaneously or following IR within a comparable time frame (21, 22, 24) . p53 312A/A mice are prone to thymic lymphomas after IR, yet their thymocytes are not resistant to apoptosis. Conversely, thymocytes derived from p53 S23A and p53 S18,23A mice are largely apoptosis-resistant, but the mice rarely develop thymic lymphomas (21, 22) . Thus, lymphoma development is perhaps not always linked to apoptotic failure in DNA-damaged thymocytes. The other principal site for tumor development in p53 312A/A mice is the liver. Liver tumors are unusual in p53-null and heterozygous mice following IR, although hepatocellular carcinomas were found in two mice with the p53 R270H/− Li-Fraumeni mutation (25) . This rarity may be due to the relatively rapid onset of other tumor types that mask the participation of the p53/p21 pathway in liver tumorigenesis (15, 18, 23, 26) .
In our study, all of the p53 312A/A mice that developed lymphomas had white coats, whereas the p53 312A/A mice that acquired liver tumors were mostly black. This mixture of coat colors reflects their mixed genetic background and may explain the tissue distribution of the tumors seen. However, p53 312A/A mice were more susceptible than either their WT or heterozygous counterparts of the same coat color to both lymphomas and liver tumors (Fig. S4) . Importantly, C57BL/6J mice (black coats) are resistant to spontaneous liver tumor development (27) , and FVB mice (white) have low lymphoma susceptibility (28) . This strongly indicates that the mutation of p53, rather than the genetic background, sensitizes these mice to tumor development. The influence of strain on tumor outcome is well documented; e.g., p53-null mice develop teratocarcinomas in a 129/Sv background, whereas p53 +/− BALB/c mice are susceptible to mammary tumors (29, 30) . Subtle variations may exist between mouse strains in pathways modulated by irradiation that may influence tumor outcome. The precise nature of such differences is currently unknown and requires more investigation. Overall, these results reinforce the hypothesis that Ser312 positively contributes to tumor suppression by p53 and hint that the fine-tuning effect of a defined p53 phosphorylation site may be tissue and stimulus dependent.
As with the untransformed MEFs in Fig. 1E , we were unable to detect phosphorylation of p53 Ser312 in WT liver or thymus following IR, despite numerous attempts. However, Ser312 was phosphorylated in irradiated E1A-transformed MEFs, suggesting that phosphorylation at this site occurs in cells already undergoing chronic (in this case, oncogenic) stress. If exposure to IR causes such a stress in vivo, the failure of p53 312A/A mice to phosphorylate These genes are among the 117 overlapping genes in Fig. 6A . Data indicate the fold change in each gene after irradiation.
Relative mRNA expression ).
Ser312 in these conditions may prevent p53 from efficiently counteracting this stress, making the mice susceptible to tumor growth. Existing studies show that IR-induced p53 in liver does not induce apoptosis, but instead induces p21-mediated cell cycle arrest (19, 31, 32) . Restoration of p53 in vivo also causes liver tumor regression via p53-mediated senescence (33) . The fact that p53 312A/A mice are prone to liver tumor development suggests that Ser312 mutation may hinder p53 by suppressing its ability to regulate cell cycle progression. This is supported by our observation that Ser312Ala mutation predisposes mice to lymphoma without affecting p53-mediated thymocyte apoptosis (Fig. 4 and Fig. S3 ). The reduced expression of p21 seen in the liver of p53 312A/A mice, and MEFs derived from p53 312A/A mice following DNA damage, correlates with previous reports that human p53 phosphorylated at Ser315 has an increased binding affinity for DNA (34) . The resulting elevated expression of p21 is reversed by mutation of Ser315 to Ala or by inhibition of cdks by roscovitine (7, 11) .
An increase in the expression of p21, but not proapoptotic genes such as Bax, has been reported in the livers of WT mice following IR exposure (32, 35) . The elevated levels of p21 persisted for at least 10 wk, implying a central role for p21 in preventing proliferation following DNA damage in the liver (35) . A reduction in p21 levels alongside altered p53 expression has also been observed in human hepatocellular carcinomas (36) . Reduced p21 expression could also explain the partial rescue of the Mdm4 phenotype, as Mdm4
−/− embryos have a similar phenotype to that seen in the Mdm4
312A/+ mice (37) . However, the number of genes whose expression varies between p53 WT and p53 312A/A mice (Fig.  6A) indicates that the difference in p21 expression is merely one element in a much more complex scenario. The fact that p21 −/− mice do not develop liver tumors, either spontaneously or following IR exposure, would seem to confirm this (38) .
This study has demonstrated that a single phosphorylation site is an important participant in tumor suppression by p53, depending upon which function is required and the site of suppression. Therefore, the many posttranslational modifications of p53 may act in a highly specific manner to subtly modify its behavior, and it is important that the contexts in which this occurs be determined.
Materials and Methods
Mice. The p53 312A/A knock-in mice were generated by inGenious Targeting
Laboratory. Mdm4 +/− mice were a generous gift from J.-C. Marine (University of Leuven) (12) . All animal procedures were approved by local ethical review and licensed by the UK Home Office.
Antibodies. The p53 phospho-Ser312 polyclonal antibody was made by immunizing rabbits with the peptide CTSApSPPQKKKP, followed by purification against the nonphosphorylated peptide to remove nonspecific antibodies. For more details, see SI Materials and Methods. 312A/A mice are significantly more susceptible to both lymphomas (P < 0.05) (Left) and tumors in general (P < 0.05) (Right) than either wild-type or p53 312A/+ mice with white coats. 
